Shanghai, China

Charles Z Ding

This inventor holds 56 USPTO granted patents and 32 published patent applications and 39 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Medshine Discovery Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Fujian Akeylink Biotechnology Co., Ltd.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Z Ding. Retrieved from https://idiyas.com/inventor/charles-z-ding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 56 

% Patents Active = 87.5

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 25(Granted Patents)

Forward Citations (Not Self Cited) = 11(Dec 10, 2025)


Company Filing History:

goldMedal15 out of 72 
 
Medshine Discovery Inc.
 patents
silverMedal11 out of 121 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
bronzeMedal4 out of 7 
 
Fujian Akeylink Biotechnology Co., Ltd.
 patents
4. 4 out of 5 
 
Luoxin Pharmaceutical (Shanghai) Co., Ltd.
 patents
5. 3 out of 6 
 
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 patents
6. 2 out of 3 
 
Fujian Cosunter Pharmaceutical Co., Ltd.
 patents
7. 2 out of 7 
 
Genfleet Therapeutics (Shanghai) Inc.
 patents
8. 2 out of 4 
 
Harbin Zhenbao Pharmaceutical Co., Ltd.
 patents
9. 2 out of 5 
 
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
 patents
10. 2 out of 4 
 
Humanwell Healthcare (Group) Co., Ltd.
 patents
11. 2 out of 13 
 
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
 patents
12. 2 out of 11 
 
Qilu Pharmaceutical Co., Ltd.
 patents
13. 2 out of 2 
 
Shenzhen Optimum Biological Technology Co., Ltd
 patents
14. 2 out of 2 
 
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
 patents
15. 1 out of 1 
 
China Resources Biopharmaceutical Company Limited
 patent
16. 1 out of 2 
 
China Resources Pharmaceutical Holdings Company Limited
 patents
17. 1 out of 2 
 
Cisen Pharmaceutical Co., Ltd
 patents
18. 1 out of 9 
 
Cstone Pharmaceuticals
 patents
19. 1 out of 5 
 
Guangdong Zhongsheng Pharmaceutical Co., Ltd
 patents
20. 1 out of 11 
 
Nanjing Sanhome Pharmaceutical Co., Ltd.
 patents
21. 1 out of 1 
 
Suzhou Erye Pharmaceutical Co., Ltd.
 patent
22. 1 out of 4 
 
Wuxi Fortune Pharmaceutical Co., Ltd
 patents
23. 1 out of 3 
 
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
 patents
24. 1 out of 1 
 
Zhuohe Pharmaceutical Group Co., Ltd
 patent
where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Indoline Compound
Pyrimidine Ring Compound
Quinazoline Compound
TLR8 Agonist
β-Lactam Antibiotics
KRAS G12C Inhibitor
Estrogen Receptor Antagonist
Antibacterial Derivatives
EGFR Inhibitor
Macrocyclic Derivatives
Hepatitis B Inhibitor
Aryl-Phosphorus-Oxygen Compound
56 patents (USPTO):Explore Patents

Title: The Innovative Journey of Charles Z Ding

Introduction: Charles Z Ding is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Charles Z Ding holds a series of recent patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his continuous commitment to innovation.

Career Highlights: With a distinguished career spanning over two decades, Charles Z Ding has worked with leading research institutions and multinational companies, playing a pivotal role in developing cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Charles Z Ding has collaborated with top universities, research institutions, and forward-thinking companies, fostering a culture of innovation and knowledge exchange.

Conclusion: Charles Z Ding's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his position as a trailblazer in the world of inventions, inspiring future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…